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Objectives. To our knowledge, the occurrence of esophagitis in children with celiac disease (CD) has never been evaluated. The
aim of this study is to determine the prevalence of esophagitis in children with CD. Patients and Methods. Between 2003 and 2007,
children with biopsy conﬁrmed CD were retrospectively identiﬁed. Biopsy reports were reviewed for esophageal inﬂammation.
Biopsy reports of 2218 endoscopies performed during the same period were also evaluated for inﬂammation. Results. Forty-nine
children diagnosed with CD (47% boys). Nineteen of 49 (39%) patients with CD had esophagitis (95% CI 0.23–0.5). Thirty
percent of boys and 46% of girls with CD had esophagitis (95% CI 0.12–0.40). Overall, 45% of patients who underwent upper
endoscopy had esophagitis. The prevalence of esophagitis in CD (39%) compared to the prevalence of esophagitis (45%) in our
practice was not signiﬁcantly diﬀerent, P = 0.2526. Conclusion. There was no diﬀerence in the prevalence of esophagitis between
children diagnosed with CD at the time of their diagnostic EGD and the prevalence of esophagitis in children without CD. A
prospective study to determine whether the esophagitis should be treated with acid suppression or whether the esophagitis heals
with the gluten-free diet is warranted.
1.Introduction
Celiac disease (CD) is an immune-mediated disease found in
genetically susceptible people of North American, European,
andMiddleEasternbackgrounds.Exposuretogluten(wheat,
barley, and rye) initiates an inﬂammatory cascade leading
to intestinal injury. CD is histologically characterized by
blunting of the villous structures and the presence of
intraepithelial lymphocytes in the small intestines. The
increase in the estimated prevalence of CD in children from
1:1000 to 1:3000 to 1:100 is likely due to the availability
of serologic markers, increased screening, and recognition of
vulnerable populations such as Down’s Syndrome and type
one diabetes [1–3].
The prevalence of esophagitis in children with known
gastroesophageal reﬂux disease (GERD) is estimated at 15–
62% [4–6] and there can be an overlap in the symptoms
associated with GERD and CD. The coexistence of esophagi-
tis in children with histologically conﬁrmed CD has not
been evaluated. The aim of this study is to determine the
prevalence of esophagitis in children with CD.
2.MaterialsandMethods
2.1. Patients. To determine the prevalence of esophagitis in
patients with CD, the records of all patients who underwent
esophagogastroduodenoscopies (EGD) with biopsies at the
Women and Children’s Hospital of Buﬀalo, University at
Buﬀalo, between January 1, 2003 through December 31,
2007, were searched for the diagnosis code 579.0 (Celiac
Disease). To determine the prevalence of esophagitis in
children undergoing EGD with biopsies, all records of EGD
from January 1, 2003 through December 31, 2007 were
reviewed. Those who had mucosal biopsies at the time of
endoscopy were included in the analysis. Patient demo-
graphics, laboratory data, clinical presentation, histology,
and endoscopy results were retrieved from oﬃce charts,
pathology reports, and electronic records.2 ISRN Gastroenterology
Table 1: Patient demographics.
Celiac disease population n = 49 Endoscopy with biopsy population n = 2218
Number (%) Mean Range SD ± Number (%) Mean Range SD ±
Number 49 2218
Age (y) 9.7 1–18 5.38 10.51 0.25–24 5.68
Gender
Males 23 (47) 1097 (49)
Age (Y) 9.39 1–18 5.63 9.55 0.25–20 5.34
Esophagitis 7/49 (14)
Females 26 (53) 1121 (51)
Age (Y) 9.98 1–18 5.24 11.46 0.25–24 5.84
Esophagitis 12/49 (24)
Esophagitis Present 19 (39) 10.09 1–17 4.98 997 (45) 10.77 0.25–24 5.55
Gender
Male 7/19 (37) 560 (56)
Age (Y) 9.37 2–14 3.98 10.27 0.25–22 5.54
Female 12/19 (63) 437 (44)
Age (Y) 12.18 5–18 3.85 11.42 0.25–24 5.49
Esophagitis absent 30 (61) 9.56 1–18 5.9 1221 (55) 10.31 0.25–24 5.76
Gender
Male 16/30 (53) 537 (44)
Age (Y) 9.4 1–18 6.34 8.84 0.25–24 6.04
Female 14/30 (47) 684 (56)
Age (Y) 7.95 1–17 5.66 11.49 0.25–20 5.24
2.2. Upper Endoscopy with Biopsies. The indications for EGD
with biopsies included abdominal pain, bloating, diarrhea,
weight loss, poor-weight gain, failure to thrive, positive
serology for tissue transglutaminase (TTG) or antien-
domysial antibody (EMA), reﬂux symptoms, and failed
treatment with acid suppression therapy. Anesthesia was
administered by pediatric anesthesiologists. All EGDs were
performed using an EG1840K or EG2730K video endo-
scope (Pentax Medical, Montvale, NJ). During Endoscopy,
esophageal (lower, mid, and upper), gastric (antrum and
fundus), and duodenal pinch biopsies were routinely
obtained using standard biopsy forceps.
2.3. Histology. All biopsies were evaluated by an experienced
pediatric pathologist at the Women and Children’s Hospital
of Buﬀalo, University at Buﬀalo [7].
2.4. Statistical Analysis. Statistical analysis was performed
by a professional statistician at the University at Buﬀalo,
Buﬀalo, NY. Statistical analyses were performed with SAS
statisticalsoftware(version9.12,2004,NC,USA).Themeans
procedure, frequency procedure, and t-tests were used to
evaluate the prevalence of esophagitis in the practice and
to compare it to the prevalence in the general population.
One-wayANOVAwasusedto evaluatethesigniﬁcanceofthe
variables versus the presence of esophagitis in patients with
CD. The diﬀerences between study groups were considered
signiﬁcant when the P value was <0.05 or when 95% CI did
not include 1.0 (equivalent to P<0.05).
3. Results
There were 3548 EGD performed between January 1, 2003
and December 31, 2007. Mucosal biopsies were obtained in
2218EGDandareincludedintheanalysis.Fortynine(2.2%)
of those had CD (age 1–18yrs, mean 9.7yrs ± SD 5.38).
Overall, 19 (39%) of those with CD had esophagitis, 95%
CI (0.23–0.51) including one patient that had eosinophilic
esophagitis. Of the 2169 patients who did not have CD,
997 (45%) had histologic evidence of esophagitis (56%
males, mean age 10.77, range 0.25–24 years) There was no
signiﬁcant diﬀerence in esophagitis between the group that
had CD and the group that did not. Patient demographics
and characteristics are summarized in Table 1. There was no
diﬀerence between the groups in any of these parameters.
4. Discussion
Gastroesophageal reﬂux and esophagitis are commonly
diagnosed in the general pediatric gastroenterology practice
and can cause signiﬁcant morbidity including missed school
days and interference with daily activities.
The prevalence of esophagitis in children with CD has
never been examined. Collin et al. [8] showed that 0.9%
of adult patients with esophagitis and 0.6% of those with
esophageal reﬂux symptoms had CD. They reported that
the prevalence of esophagitis was 5.2% in untreated CD,
5.6% in treated CD, and 27% in symptomatic reﬂux disease.
The reﬂux symptoms in celiac patients were mild; however,
the symptoms were alleviated on a gluten-free diet (GFD).ISRN Gastroenterology 3
Their conclusion was that patients with reﬂux esophagitis
should not be screened for CD. However, Cuomo et al. [9]
showed that adult patients with CD have a higher prevalence
of reﬂux esophagitis than those without CD and suggest
that CD may represent a risk factor for the development
of reﬂux esophagitis. Our data showed no diﬀerence in
the prevalence of esophagitis between those who have CD
and those who underwent EGD but did not have CD. Our
population is diﬀerent from the populations reported on by
Cuomo and Collin in that our data is limited to children and
adolescents. Our data suggests that it is prudent to obtain
esophageal biopsies at the time of the diagnostic EGD for
CD and to consider repeating esophageal biopsies on those
who continue to be symptomatic despite GFD and acid
suppression.
It is important to note that there is no data on the
prevalence of esophagitis in the general population of
children and adolescents. This study shows the prevalence of
esophagitis in patients who presented with symptoms that
required an EGD. It is expected that these patients would
have a higher prevalence of esophagitis than those in the
general population. Since the prevalence of esophagitis in
patients with CD is statistically similar to the prevalence of
esophagitis in patients who did not have CD but patients
whose symptoms warranted an EGD, it is reasonable to
assume that esophagitis occurs with greater frequency in
patients with CD than in the general population.
SincepatientswithCDdidnothavetorepeatEGD,wedo
not know if the esophagitis resolved on a GFD. Patients with
coexistent CD and esophagitis showed clinical improvement
when treated with both acid suppression and GFD. Thus, we
were unable to determine if the clinical improvement was
from acid suppression, GFD, or both.
Finally, esophageal biopsies can also exclude eosinophilic
esophagitis (EE), a diagnosis that has been on the rise
over the past 15–20 years. Although, we only identiﬁed one
patient with CD who concomitantly had EE, there are several
case reports and reviews on the increased prevalence of EE in
patients with CD compared to the prevalence of EE in the
general population [10, 11].
5. Conclusion
There was no diﬀerence in the prevalence of esophagitis
between children diagnosed with CD at the time of their
diagnostic EGD and prevalence of esophagitis in children
without CD undergoing EGD. A prospective study to
determine whether there is a need to treat the esophagitis
with acid suppression therapy or whether the esophagitis
heals with the gluten-free diet is warranted.
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